QuickView for PLA2G16;jsessionid=DE4E0C148F45692259CEDA63456D514B;jsessionid=1F90A47A3463DDDF8FE9258495AD3843;jsessionid=E1836A9470168DAB9AAB82762F090970;jsessionid=C7E9253E770C2FC4F220DED0AEC59035;jsessionid=FD2104A3623093315766DF6433DC8474;jsessionid=DE2F5D9377BD536FA942E6DD60CB1E27;jsessionid=2C59D73853ADE3927DF7A80BD1FF2C1C (gene)

1. Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant prog…
2. Transdermal Delivery of Adipocyte Phospholipase A2 siRNA using Microneedles to Treat Thyroid Associa…
3. Bypassing pan-enterovirus host factor PLA2G16.
4. PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
5. High expression of PLA2G16 is associated with a better prognosis in HER2-positive breast cancer.

There were no clinical trials for PLA2G16;jsessionid=DE4E0C148F45692259CEDA63456D514B;jsessionid=1F90A47A3463DDDF8FE9258495AD3843;jsessionid=E1836A9470168DAB9AAB82762F090970;jsessionid=C7E9253E770C2FC4F220DED0AEC59035;jsessionid=FD2104A3623093315766DF6433DC8474;jsessionid=DE2F5D9377BD536FA942E6DD60CB1E27;jsessionid=2C59D73853ADE3927DF7A80BD1FF2C1C